AC Immune SA (ACIU) DCF Valuation

Valoración de DCF de AC Immune SA (ACIU)

CH | Healthcare | Biotechnology | NASDAQ
AC Immune SA (ACIU) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

AC Immune SA (ACIU) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Explore el futuro financiero de AC Immune SA (ACIU) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones para el crecimiento, los márgenes y los costos para calcular el valor intrínseco de AC inmune SA (ACIU) e informar sus decisiones de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 123.3 17.1 .0 4.4 16.4 12.9 10.1 7.9 6.2 4.9
Revenue Growth, % 0 -86.1 -100 0 276.14 -21.53 -21.53 -21.53 -21.53 -21.53
EBITDA 49.5 -68.1 -85.7 -76.7 -57.6 -4.1 -3.2 -2.5 -2.0 -1.6
EBITDA, % 40.11 -396.99 100 -1754.87 -350.19 -31.98 -31.98 -31.98 -31.98 -31.98
Depreciation 1.9 2.2 2.1 2.6 2.5 4.9 3.8 3.0 2.4 1.9
Depreciation, % 1.53 12.75 100 59.95 14.97 37.84 37.84 37.84 37.84 37.84
EBIT 47.6 -70.2 -87.8 -79.3 -60.0 -4.2 -3.3 -2.6 -2.0 -1.6
EBIT, % 38.59 -409.74 100 -1814.82 -365.16 -32.28 -32.28 -32.28 -32.28 -32.28
Total Cash 320.6 251.0 220.2 136.2 114.5 12.9 10.1 7.9 6.2 4.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.2 1.8 1.1 .9 16.7
Account Receivables, % 0.98626 10.31 100 20.33 101.66
Inventories -1.6 -2.1 -1.6 .0 .0 2.2 1.7 1.4 1.1 .8
Inventories, % -1.26 -12.44 100 0.000025412961 0 17.26 17.26 17.26 17.26 17.26
Accounts Payable .2 2.4 2.2 1.0 1.9 3.9 3.0 2.4 1.9 1.5
Accounts Payable, % 0.1279 14.15 100 23.61 11.34 29.85 29.85 29.85 29.85 29.85
Capital Expenditure -2.1 -1.9 -2.9 -1.4 -.9 -1.3 -1.0 -.8 -.6 -.5
Capital Expenditure, % -1.7 -11.06 100 -31.49 -5.41 -9.93 -9.93 -9.93 -9.93 -9.93
Tax Rate, % -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236 -0.01844236
EBITAT 47.6 -70.5 -87.8 -79.4 -60.1 -4.2 -3.3 -2.6 -2.0 -1.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 47.9 -67.9 -88.7 -80.7 -73.5 9.9 .5 .4 .3 .2
WACC, % 10.39 10.39 10.39 10.39 10.39 10.39 10.39 10.39 10.39 10.39
PV UFCF
SUM PV UFCF 10.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 3
Present Terminal Value 2
Enterprise Value 12
Net Debt -83
Equity Value 95
Diluted Shares Outstanding, MM 85
Equity Value Per Share 1.12

What You Will Get

  • Real AC Immune Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for AC Immune SA (ACIU).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to AC Immune SA (ACIU).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on AC Immune SA (ACIU)'s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for AC Immune SA (ACIU).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for AC Immune SA (ACIU).

Key Features

  • Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for AC Immune SA (ACIU).
  • Adjustable Projection Parameters: Modify highlighted cells for metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
  • Suitable for All Levels: Designed for investors, CFOs, and consultants with a straightforward, easy-to-navigate layout.

How It Works

  • Step 1: Download the prebuilt Excel template featuring AC Immune SA’s (ACIU) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including AC Immune SA’s (ACIU) intrinsic value.
  • Step 5: Use the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator for AC Immune SA (ACIU)?

  • Accuracy: Utilizes real AC Immune financials to ensure precise data.
  • Flexibility: Tailored for users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected by CFOs.
  • User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Accurately assess AC Immune SA’s (ACIU) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to AC Immune SA (ACIU).
  • Consultants: Efficiently modify the template for valuation reports tailored to AC Immune SA (ACIU) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms like AC Immune SA (ACIU).
  • Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to AC Immune SA (ACIU).

What the Template Contains

  • Pre-Filled DCF Model: AC Immune SA’s (ACIU) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate AC Immune SA’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.